(Q43605821)

25 November 2017

P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours (English)

1 reference

25 November 2017

Baltaci S

1

1 reference

25 November 2017

Orhan D

2

1 reference

25 November 2017

Türkölmez K

3

1 reference

25 November 2017

Yesilli C

4

1 reference

25 November 2017

Bedük Y

5

1 reference

25 November 2017

Tulunay O

6

1 reference

25 November 2017

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

87

1 reference

25 November 2017

661-666

1 reference

25 November 2017

7

1 reference

Poor-risk germ cell tumors. Recent developments.

25 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02151.X

Apoptosis in cancer therapy: crossing the threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02151.X

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02151.X

Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02151.X

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02151.X

Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02151.X

Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02151.X

10.1046/J.1464-410X.2001.02151.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference